China Yongxin Pharmaceuticals Inc. (CIK: 0001087848) EDGAR, Information, Filings... CompaniesBIO.Com

China Yongxin Pharmaceuticals Inc.

Mailing address
927 CANADA CT., CITY OF INDUSTRY, Delaware, 91748
Phone
626-581-9098
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
5122 - (CF Office: Office of Trade & Services) WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Filings
N/A

China Yongxin Pharmaceuticals Inc. (CIK: 0001087848) is an American company incorporated in the state of California. Head office is located at 927 CANADA CT., CITY OF INDUSTRY, California, 91748. Work in the industry 5122 - (CF Office: Office of Trade & Services) WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES. China Yongxin Pharmaceuticals Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Nutradyne Group, Inc. from 2008-01-Apr to 2008-09-May
Nutradyne, Inc. from 2007-11-Jul to 2007-26-Nov
Digital Learning Management CO from 2006-03-Aug to 2007-14-Sep
DIGITAL LEARNING from 2004-07-Apr to 2006-22-May
FREEPCSQUOTE COM from 1999-05-Nov to 2004-05-Apr

Owner	Filings	Transaction Date	Type of Owner
Philips Laura A	0001401312	Aug-20-2010	director
LI Bing	0001487115	Jun-28-2010	director
WANG Jingang	0001487116	Jun-28-2010	director
LIEBERMAN Hal	0001487082	Mar-03-2010	director
LIU YONGXIN	0001438586	Dec-16-2009	director, 10 percent owner, officer: CEO and Chairman
Zhang Harry	0001478681	Dec-04-2009	director, officer: Chief Financial Officer
WANG YONGMEI	0001438587	Nov-16-2007	10 percent owner
LIU YONGKUI	0001438834	Nov-16-2007	10 percent owner
LIU Ning	0001486854	Nov-16-2007	director, officer: President and COO
Boom Day Investments Ltd.	0001487106	Nov-16-2007	10 percent owner
Misala Holdings Inc.	0001487107	Nov-16-2007	10 percent owner
FRAZER GREGORY J	0001054845	Mar-08-2004	director
SHEIKH KHALID M A	0001284024	Mar-08-2004	director
PEARSON ROBERT C	0001129793	Mar-02-2004	director
RAPPAPORT RICHARD	0001283175	Mar-02-2004	director
JINNAH AL	0001277398	Jan-20-2004	officer: Secretary
PATEL UMESH	0001277399	Jan-20-2004	director, 10 percent owner, officer: Chief Financial Officer
BHATTI AURANGZEB	0001277401	Jan-20-2004	director, 10 percent owner, officer: President

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by China Yongxin Pharmaceuticals Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
REVOKED	Document	Acc-no: 9999999997-12-014947 (34 Act) Size: KB	Dec-04-2012	000-26293 121239307
NT 10-K	Document	Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001213900-11-001651 (34 Act) Size: KB	Mar-31-2011	000-26293 11725012
RW	Document	Registration Withdrawal Request Acc-no: 0001144204-11-005015 (NE Act) Size: KB	Jan-31-2011	333-167416 11560351
8-K	Document	Current report filing Acc-no: 0001144204-10-065758 (34 Act) Size: KB	Dec-10-2010	000-26293 101244041
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-10-062772 (34 Act) Size: KB	Nov-22-2010	000-26293 101208321
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001144204-10-061364 (34 Act) Size: KB	Nov-16-2010	000-26293 101196298
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001144204-10-057347 (33 Act) Size: KB	Nov-04-2010	333-167416 101162502
DEF 14A	Document	Definitive proxy statements Acc-no: 0001144204-10-048375 (34 Act) Size: KB	Sep-07-2010	000-26293 101060364
PRER14A	Document	Preliminary revised proxy soliciting materials Acc-no: 0001144204-10-047178 (34 Act) Size: KB	Aug-27-2010	000-26293 101044917
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-10-046377 ( Act) Size: 0 KB	Aug-24-2010
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001144204-10-045958 (34 Act) Size: KB	Aug-20-2010	000-26293 101030730
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001144204-10-044166 (34 Act) Size: KB	Aug-16-2010	000-26293 101017609
S-1/A	Document	Amendment to General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001144204-10-040979 (33 Act) Size: KB	Aug-03-2010	333-167416 10988520
8-K	Document	Current report filing Acc-no: 0001144204-10-036307 (34 Act) Size: KB	Jul-02-2010	000-26293 10934685
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001487082-10-000004 ( Act) Size: 0 KB	Jun-30-2010
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001487082-10-000003 ( Act) Size: 0 KB	Jun-30-2010
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001487082-10-000002 ( Act) Size: 0 KB	Jun-30-2010
S-1	Document	General form of registration statement for all companies including face-amount certificate companies Acc-no: 0001144204-10-032639 (33 Act) Size: KB	Jun-09-2010	333-167416 10887481
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001401312-10-000005 ( Act) Size: 0 KB	Jun-03-2010
8-K	Document	Current report filing Acc-no: 0001144204-10-030175 (34 Act) Size: KB	May-25-2010	000-26293 10856219

Recent 20 filings. View all China Yongxin Pharmaceuticals Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

China Yongxin Pharmaceuticals Inc. overview
China Yongxin Pharmaceuticals Inc. job
China Yongxin Pharmaceuticals Inc. stock
China Yongxin Pharmaceuticals Inc. ownership
China Yongxin Pharmaceuticals Inc. CEO
China Yongxin Pharmaceuticals Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.